122 related articles for article (PubMed ID: 10560332)
1. Evaluation of 18F-FDG positron emission tomography in gastric and oesophageal carcinoma.
McAteer D; Wallis F; Couper G; Norton M; Welch A; Bruce D; Park K; Nicolson M; Gilbert FJ; Sharp P
Br J Radiol; 1999 Jun; 72(858):525-9. PubMed ID: 10560332
[TBL] [Abstract][Full Text] [Related]
2. Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma.
Rankin SC; Taylor H; Cook GJ; Mason R
Clin Radiol; 1998 Sep; 53(9):659-65. PubMed ID: 9766719
[TBL] [Abstract][Full Text] [Related]
3. Detection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric cancer.
Couper GW; McAteer D; Wallis F; Norton M; Welch A; Nicolson M; Park KG
Br J Surg; 1998 Oct; 85(10):1403-6. PubMed ID: 9782025
[TBL] [Abstract][Full Text] [Related]
4. Serial imaging using [18F]Fluorodeoxyglucose positron emission tomography and histopathologic assessment in predicting survival in a population of surgically resectable distal oesophageal and gastric adenocarcinoma following neoadjuvant therapy.
Manoharan V; Lee S; Chong S; Yap J; Coupe N; Wilson R; Merrett N; Ng W; Lin M
Ann Nucl Med; 2017 May; 31(4):315-323. PubMed ID: 28299585
[TBL] [Abstract][Full Text] [Related]
5. Impact of FDG-PET for staging of oesophageal cancer.
Imdahl A; Hentschel M; Kleimaier M; Hopt UT; Brink I
Langenbecks Arch Surg; 2004 Aug; 389(4):283-8. PubMed ID: 15197549
[TBL] [Abstract][Full Text] [Related]
6. The utility of FDG-PET for detecting multiple primary cancers in hypopharyngeal cancer patients.
Kaida H; Ishibashi M; Kurata S; Uchiyama Y; Tanaka N; Abe T; Kobayashi M; Kaibara H; Uchida M; Nakashima T; Fujita H; Hayabuchi N
Nuklearmedizin; 2009; 48(5):179-84. PubMed ID: 19639163
[TBL] [Abstract][Full Text] [Related]
7. The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma.
Chowdhury FU; Bradley KM; Gleeson FV
Clin Radiol; 2008 Dec; 63(12):1297-309. PubMed ID: 18996259
[TBL] [Abstract][Full Text] [Related]
8. PET and PET-CT in esophageal and gastric cancer.
Wieder HA; Krause BJ; Herrmann K
Methods Mol Biol; 2011; 727():59-76. PubMed ID: 21331929
[TBL] [Abstract][Full Text] [Related]
9. Carbon-11 choline or FDG-PET for staging of oesophageal cancer?
Jager PL; Que TH; Vaalburg W; Pruim J; Elsinga P; Plukker JT
Eur J Nucl Med; 2001 Dec; 28(12):1845-9. PubMed ID: 11734925
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopy, computerised tomography and fluorodeoxyglucose positron emission tomography in the management of gastric and gastro-oesophageal junction cancers.
Mirza A; Galloway S
Surg Endosc; 2016 Jul; 30(7):2690-6. PubMed ID: 26487234
[TBL] [Abstract][Full Text] [Related]
11. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
Cuellar SL; Carter BW; Macapinlac HA; Ajani JA; Komaki R; Welsh JW; Lee JH; Swisher SG; Correa AM; Erasmus JJ; Hofstetter WL
J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774
[TBL] [Abstract][Full Text] [Related]
12. The role of PET scan in the preoperative management of oesophageal cancer.
Liberale G; Van Laethem JL; Gay F; Goldman S; Nagy N; Coppens E; Gelin M; El Nakadi I
Eur J Surg Oncol; 2004 Nov; 30(9):942-7. PubMed ID: 15498638
[TBL] [Abstract][Full Text] [Related]
13. The value of vesicant 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) in gastric malignancies.
Tian J; Chen L; Wei B; Shao M; Ding Y; Yin D; Yao S
Nucl Med Commun; 2004 Aug; 25(8):825-31. PubMed ID: 15266178
[TBL] [Abstract][Full Text] [Related]
14. Visualisation of metastatic oesophageal and gastric cancer and prediction of clinical response to palliative chemotherapy using 18FDG PET.
Lorenzen S; Herrmann K; Weber WA; Wieder H; Hennig M; Ott K; Bredenkamp R; Peschel C; Schwaiger M; Lordick F
Nuklearmedizin; 2007; 46(6):263-70. PubMed ID: 18084682
[TBL] [Abstract][Full Text] [Related]
15. Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies.
Smyth EC; Shah MA
World J Gastroenterol; 2011 Dec; 17(46):5059-74. PubMed ID: 22171140
[TBL] [Abstract][Full Text] [Related]
16. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET in the initial staging of squamous cell oesophageal carcinoma.
Buchmann I; Hansen T; Brochhausen C; Kneist W; Oberholzer K; Junginger T; Schreckenberger M; Bartenstein P
Nuklearmedizin; 2006; 45(6):235-41. PubMed ID: 17149491
[TBL] [Abstract][Full Text] [Related]
18. [Fluorine-18 fluorodeoxyglucose-positron emission tomography imaging of carcinoma of cardia or fundus of stomach].
Wang T; Sun YE; Yu CH; Chang P; Yao SL; Tian JH; Wu X; Sun K; Yang B
Zhonghua Wai Ke Za Zhi; 2006 May; 44(10):661-4. PubMed ID: 16784672
[TBL] [Abstract][Full Text] [Related]
19. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography.
Flanagan FL; Dehdashti F; Siegel BA; Trask DD; Sundaresan SR; Patterson GA; Cooper JD
AJR Am J Roentgenol; 1997 Feb; 168(2):417-24. PubMed ID: 9016218
[TBL] [Abstract][Full Text] [Related]
20. Neoplasms of the esophagus and stomach.
Dehdashti F; Siegel BA
Semin Nucl Med; 2004 Jul; 34(3):198-208. PubMed ID: 15202101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
